The impact of pre‐transplant obesity on renal transplant outcomes

The impact of obesity on graft survival after renal transplantation continues to be controversial. We have reviewed our experiences with living donor and cadaver transplantation in the current decade, focusing specifically on the impact of obesity on transplant outcome. Preoperative body mass index...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical transplantation 1997-10, Vol.11 (5pt2), p.493-496
Hauptverfasser:	Drafts, H. H., Anjum, M. R., Wynn, J. J., Mulloy, L. L., Bowley, J. N., Humphries, A. L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Azathioprine - therapeutic use Body Mass Index Cadaver Cyclosporine - administration & dosage Diabetes Mellitus - etiology Female Glucocorticoids - therapeutic use Graft Survival Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - therapeutic use kidney transplantation Kidney Transplantation - immunology Kidney Transplantation - physiology Living Donors Male Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use obesity Obesity - immunology Obesity - physiopathology Obesity, Morbid - physiopathology outcomes Prednisone - therapeutic use Surgical Wound Infection - etiology Survival Rate Transplantation, Homologous Treatment Outcome Weight Gain
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!